These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17361348)

  • 1. Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.
    Morís G; Ribacoba R; González C
    J Neurol; 2007 Apr; 254(4):534-5. PubMed ID: 17361348
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
    Skelton MR; Goldberg RM; O'Neil BH
    Clin Colorectal Cancer; 2007 Jan; 6(5):386-8. PubMed ID: 17311705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemox: a widely useful therapy against solid tumors-review and personal experience.
    Meriggi F; Zaniboni A
    J Chemother; 2010 Oct; 22(5):298-303. PubMed ID: 21123151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hand-foot syndrome related to chemotherapy.
    Qiao J; Fang H
    CMAJ; 2012 Oct; 184(15):E818. PubMed ID: 22508979
    [No Abstract]   [Full Text] [Related]  

  • 5. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
    Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
    Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary.
    Carlson H; Lenzi R; Raber MN; Varadhachary GR
    Int J Clin Oncol; 2013 Apr; 18(2):226-31. PubMed ID: 22218909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
    Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
    Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers.
    Goff LW; Cardin DB; Whisenant JG; Du L; Koyama T; Dahlman KB; Salaria SN; Young RT; Ciombor KK; Gilbert J; Smith SJ; Chan E; Berlin J
    Invest New Drugs; 2017 Feb; 35(1):95-104. PubMed ID: 27853997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of outpatient biweekly gemcitabine-oxaliplatin in advanced biliary tract carcinomas.
    Halim A; Ebrahim MA; Saleh Y
    Jpn J Clin Oncol; 2011 Feb; 41(2):217-24. PubMed ID: 21062755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.
    Culine S; Rebillard X; Iborra F; Mottet N; Faix A; Ayuso D; Pinguet F
    Anticancer Res; 2003; 23(2C):1903-6. PubMed ID: 12820476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of gemcitabine combined with S-1 in the treatment of advanced pancreatic cancer].
    Jiang Y; Zhong H; He P; Zheng L; Yang K
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):472-5. PubMed ID: 26463154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.
    Qin TJ; Zhao XH; Yun J; Zhang LX; Ruan ZP; Pan BR
    World J Gastroenterol; 2008 Sep; 14(33):5210-6. PubMed ID: 18777599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
    Lopes G; Quesada J; Ahn E; Flores A; Ribeiro A; Rocha-Lima CM
    Clin Colorectal Cancer; 2007 Sep; 6(9):641-5. PubMed ID: 17945036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
    Lee J; Park SH; Chang HM; Kim JS; Choi HJ; Lee MA; Jang JS; Jeung HC; Kang JH; Lee HW; Shin DB; Kang HJ; Sun JM; Park JO; Park YS; Kang WK; Lim HY
    Lancet Oncol; 2012 Feb; 13(2):181-8. PubMed ID: 22192731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.
    Ch'ang HJ; Huang CL; Wang HP; Shiah HS; Chang MC; Jan CM; Chen JS; Tien YW; Hwang TL; Lin JT; Cheng AL; Whang-Peng J; Chen LT
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1173-9. PubMed ID: 19319535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study.
    Androulakis N; Syrigos K; Polyzos A; Aravantinos G; Stathopoulos GP; Ziras N; Mallas K; Vamvakas L; Georgoulis V;
    Cancer Invest; 2005; 23(1):9-12. PubMed ID: 15779862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
    Correale P; Messinese S; Caraglia M; Marsili S; Piccolomini A; Petrioli R; Ceciarini F; Micheli L; Nencini C; Neri A; Vuolo G; Guarnieri A; Abbruzzese A; Prete SD; Giorgi G; Francini G
    Br J Cancer; 2004 May; 90(9):1710-4. PubMed ID: 15150625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.
    Saif MW; Syrigos K; Kaley K; Isufi I
    Anticancer Res; 2010 Jul; 30(7):2927-33. PubMed ID: 20683034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.
    Park BB; Kim WS; Eom HS; Kim JS; Lee YY; Oh SJ; Lee DH; Suh C
    Invest New Drugs; 2011 Feb; 29(1):154-60. PubMed ID: 19756371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.